Purified anti-β-Amyloid, 1-16 Antibody (Previously Covance catalog# SIG-39320)

Pricing & Availability
Clone
6E10 (See other available formats)
Regulatory Status
RUO
Other Names
AAA, ABETA, ABPP, AD1, APPI, CTFgamma, CVAP, PN-II, PN2, Amyloid beta A4 protein, preA4, protease, peptidase nexin-II, beta-amyloid peptide, alzheimer disease amyloid protein, cerebral vascular amyloid peptide, APP, Amyloid Precursor Protein
Previously
Signet Catalog# 9320-02
Signet Catalog# 9320-05
Signet Catalog# 9320-10
Covance Catalog# SIG-39320
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_6E10_PURE_betaAmyloid_1-16_WB_050818
Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • A_6E10_PURE_betaAmyloid_1-16_WB_050818
    Western blot of purified anti-β-amyloid, 1-16 antibody (clone 6E10). Lane 1: Molecular weight marker; Lane 2: 50 ng of the human Aβ1-40 peptide; Lane 3: 50 ng of the Aβ1-42 peptide; Lane 4: 50 ng of the recombinant human APP751 protein; Lane 5: 20µg of the human brain lysate; Lane 6: 50 ng of the rodent Aβ1-42 peptide. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with the HRP goat anti-mouse IgG antibody (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
  • B_6E10_PURE_betaAmyloid_1-16_DirectELISA_050818
    Direct ELISA of purified anti-β-amyloid 1-16 (clone 6E10) antibody binding to the plate-immobilized human Aβ1-40 and the recombinant human APP751. ELISA was performed by coating the wells with 100 ng of peptide or recombinant protein. The wells were then incubated with the primary antibody at 37°C for 45 minutes, followed by incubation with HRP labeled goat anti-mouse IgG secondary antibody. TMB (3, 3', 5, 5' tetramethylbenzidine, Cat. No. 421501) was used as the detection system.
  • C_6E10_PURE_betaAmyloid_1-16_IHCP_050818
    IHC staining of purified anti-β-Amyloid, 1-16 antibody (clone 6E10) on the formalin-fixed paraffin-embedded normal human (left panel) and Alzheimer’s disease (right panel) brain tissues. Following antigen retrieval using 70% formic acid for 20 minutes, the tissues were incubated with 1µg/mL of the primary antibody for 1 hour at room temperature. BioLegend’s Ultra-Streptavidin (USA) HRP Detection Kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The images were captured with a 40X objective. Scale bar: 50 µm
Cat # Size Price Quantity Avail. Save
803003 1 mL 1215,20€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803004 25 µL 76,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803001 200 µL 377,60€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
803002 500 µL 738,40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Alzheimer's disease is characterized by the accumulation of aggregated Aβ peptides in senile plaques and vascular deposits. Aβ peptides are derived from amyloid precursor proteins (APP) through sequential proteolytic cleavage of APP by β-secretases and γ-secretases generating diverse Aβ species. Aβ can aggregate to form soluble oligomeric species and insoluble fibrillar or amorphous assemblies. Some forms of the aggregated peptides are toxic to neurons.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution (no preservatives or carrier proteins).
Preparation
The antibody was purified by affinity chromatography.
Concentration
1 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
Application

WB - Quality tested
Direct ELISA, IHC-P Verified
IHC-F, EM, ICC -  Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by western blotting. For western blotting, the suggested use of this reagent is 1 µg/mL. For Direct ELISA, the suggested use of this reagent is 0.002 - 0.02 µg/mL. For immunohistochemistry on formalin-fixed paraffin-embedded tissue sections, the suggested use of this reagent is 0.2 - 5.0 µg/mL. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody is reactive to amino acid residue 1-16 of beta amyloid. The epitope lies within amino acids 3-8 of beta amyloid (EFRHDS).

This antibody clone has been reported for use in immunohistochemistry of free-floating sections2,13.

Additional Product Notes

View more applications data for this product in our Scientific Poster Library.

Application References

(PubMed link indicates BioLegend citation)
  1. Thakker DR, et al. 2009. Proc. Natl. Acad. Sci. USA. 106(11):4501-6. (IHC) PubMed
  2. Oddo S, et al. 2005. Proc. Natl. Acad. Sci. USA. 102(8):3046-51. (IHC-other) PubMed
  3. Herzig M, et al. 2004. Nat. Neuro. 7(9):954-959. (WB) PubMed
  4. Zheng Y, et al. 2012. PLoS One 6:39035. (IHC-F) PubMed
  5. Abramowksi D, et al. J Neurosci. 32:1273. (WB) PubMed
  6. Forny-Germano L, et al. 2014. J. Neurosci. 34:13629. (WB, IHC) PubMed
  7. Gowert NS, et al. 2014. PLoS One 2:e90523. (ICC, EM) PubMed
  8. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. (IHC-F)
  9. Kumar R, et al. 2016. Brain. 139:174-92 (WB)
  10. Miyamoto T, et al. 2016. J. Biol. Chem. 291:1719-34. (WB)
  11. Saito S, et al. 2017. Acta Neuropathol. Commun. 5:26-9. (IHC-P) PubMed
  12. Omata Y, et al. 2016. Aging (Albany NY) 8(3):427. (IHC-P) PubMed
  13. Peng W, et al. 2016. Neurobiol. Dis. 93:215. (IHC-other) PubMed
  14. Mandler M, et al. 2015. PLoS One. e0115237. (WB, IHC, ELISA) PubMed
Product Citations
  1. Sandoval-Hernández A, et al. 2015. PLoS One. 10: 0145467. PubMed
  2. Kumar R, et al. 2016. Brain. 139: 174 - 192. PubMed
  3. Miyamoto T, et al. 2016. J Biol Chem. 291: 1719 - 1734. PubMed
  4. Baruch K, et al. 2016. Nat Med. 22:135-137. PubMed
  5. Fu A, et al. 2016. Proc Natl Acad Sci U S A. 113: 2705 - 2713. PubMed
  6. Donner L, et al. 2016. Sci Signal. 9: ra52. PubMed
  7. Cifelli J, et al. 2016. J Biol Chem. 291: 11981 - 11992. PubMed
  8. Hernandez-Rapp J, et al. 2016. Sci Rep. 6:30953. PubMed
  9. Pan H, et al. 2016. Stem Cell Reports. 7:707-718. PubMed
  10. Salta E, et al. 2016. EMBO Mol Med. 8: 1005 - 1018. PubMed
  11. Sherman M, et al. 2016. J Neurosci. 36: 9647 - 9658. PubMed
  12. Reinders N, et al. 2016. Proc Natl Acad Sci U S A. 113: E6526 - E6534. PubMed
  13. Hostetler E, et al. 2016. J Nucl Med. 57: 1599 - 1606. PubMed
  14. A Kimura, S Hata, T Suzuki 2016. J Biol Chem. 291: 24041 - 24053. PubMed
  15. Daria A, et al. 2017. EMBO J. 10.15252/embj.201694591. PubMed
  16. Flanagan M, et al. 2017. J Neuropathol Exp Neurol. 10.1093/jnen/nlw104. PubMed
  17. Yang S, et al. 2017. EMBO Mol Med. 9(1):61-77. PubMed
  18. Augé E, et al. 2017. Sci Rep. 7:41807. PubMed
  19. Kirouac L et al. 2015. eNeuro. 4(2) pii: ENEURO. PubMed
  20. Koronyo-Hamaoui M, et al. 2020. Brain. 143:336. PubMed
  21. Cen X, et al. 2020. Nat Commun. 4.438194444. PubMed
  22. Cho YY, et al. 2020. Molecules. 25:00:00. PubMed
  23. Leal NS, et al. 2020. Cells. 9:00. PubMed
  24. Jeon SH, et al. 2020. Int J Mol Sci. 21:00. PubMed
  25. Huang L, et al. 2020. Cell Death Dis. 1.033333333. PubMed
  26. Guo X, et al. 2020. Aging Dis. 1.446527778. PubMed
  27. Lin L, et al. 2020. Acta Neuropathol Commun. 0.470138889. PubMed
  28. Montalbano M, et al. 2020. Neurobiol Dis. 146:105130. PubMed
  29. Doustar J, et al. 2020. Aging Cell. :e13246. PubMed
  30. Liu D, et al. 2020. J Neuroinflammation. 0.8875. PubMed
  31. Lee Y, et al. 2020. Sci Rep. 10:16144. PubMed
  32. Mo D, et al. 2020. Cells. 9:00. PubMed
  33. Farid MM, et al. 2020. Sci Rep. 10:16424. PubMed
  34. von Saucken VE, et al. 2020. Neurobiol Dis. 145:105072. PubMed
  35. Ikonomovic MD, et al. 2020. Acta Neuropathol. 140:463. PubMed
  36. Pérez-González R, et al. 2020. FASEB J. 34:12922. PubMed
  37. Lackie RE, et al. 2020. Acta Neuropathol Commun. 0.432638889. PubMed
  38. Shi Y, et al. 2020. J Alzheimers Dis. 76:1375. PubMed
  39. Neddens J, et al. 2020. PLoS One. 15:e0235543. PubMed
  40. Ren JM, et al. 2020. Mol Med Rep. 2.349305556. PubMed
  41. Zhang H, et al. 2020. J Neurosci. 40:5347. PubMed
  42. Reed-Geaghan EG, et al. 2020. J Exp Med. 217:00:00. PubMed
  43. Maron R, et al. 2020. International Journal of Molecular Sciences. 21(9):. PubMed
  44. Colombo AV, et al. 2021. eLife. 10:00. PubMed
  45. Hsu CN, et al. 2021. PLOS Computational Biology. 17(5):e1008967. PubMed
  46. Chen WT, et al. 2020. Cell. 182(4):976-991.e19. PubMed
  47. La Barbera L, et al. 2021. Progress in Neurobiology. 202:102031. PubMed
  48. Bourdenx M, et al. 2021. Cell. 184(10):2696-2714.e25. PubMed
  49. Martin L, et al. 2021. Cell Reports. 35(6):109121. PubMed
  50. Hung C, et al. 2021. Cell Reports. 35(11):109259. PubMed
  51. Dore K, et al. 2021. Cell Reports. 35(9):109194. PubMed
  52. Willén K, et al. 2017. Mol Neurodegener. 10.1186/s13024-017-0203-y. PubMed
  53. Rocchi A, et al. 2017. PLoS Genet.. 10.1371/journal.pgen.1006962. PubMed
  54. Park J,et al. 2017. J Radiat Res.. 10.1093/jrr/rrx045. PubMed
  55. Zhi D, et al. 2017. Sci Rep. 10.1038/s41598-017-11628-9. PubMed
  56. Chen L, et al. 2017. Sci Rep. 10.1038/s41598-017-12484-3. PubMed
  57. Faraz A, et al. 2017. Antioxid Redox Signal. . 10.1089/ars.2016.6860. PubMed
  58. Casali BT, et al. 2018. J Neuroinflammation. 15:43. PubMed
  59. Matthes F, et al. 2018. Cell Death Discov. 4:4. PubMed
  60. Kim W, et al. 2018. Mol Neurodegener. 13:6. PubMed
  61. Aisling Chaney et al. 2017. Journal of neurochemistry. 144(3):318-335 . PubMed
  62. Datta M, et al. 2018. Immunity. 48:514. PubMed
  63. Ahmad F et al. 2018. Scientific reports. 8(1):13119 . PubMed
  64. Pan RY, et al. 2019. Sci Adv. 5:eaau6328. PubMed
  65. Chiang ACA, et al. 2018. Am J Pathol. 188:739. PubMed
  66. Hung COY et al. 2018. Cell reports. 25(13):3647-3660 . PubMed
  67. Kulas JA, et al. 2017. J Endocrinol. 235:49. PubMed
  68. Yang C, et al. 2017. Autophagy. :0. PubMed
  69. Bartolotti N, et al. 2018. J Alzheimers Dis. 66:1425. PubMed
  70. Sun J, et al. 2019. Nat Commun. 10:53. PubMed
  71. Limbocker R, et al. 2019. Nat Commun. 10:225. PubMed
  72. Leonetti M, et al. 2019. Sci Rep. 9:4591. PubMed
  73. Harach T, et al. 2017. Sci Rep. 7:41802. PubMed
  74. Poksay KS, et al. 2017. Front Pharmacol. 8:46. PubMed
  75. Xia F, et al. 2017. Neuropsychopharmacology. 42:2493. PubMed
  76. Wang X, et al. 2017. Front Aging Neurosci. 9:157. PubMed
  77. Chandramowlishwaran P, et al. 2018. J Biol Chem. 293:3436. PubMed
  78. Song M, et al. 2018. Genes (Basel). 9:. PubMed
  79. Dong ZZ, et al. 2018. Int J Ophthalmol. 11:747. PubMed
  80. Rosenzweig N, et al. 2019. Nat Commun. 10:465. PubMed
  81. Sri S, et al. 2019. Acta Neuropathol Commun. 7:25. PubMed
  82. Feng T, et al. 2017. J Biol Chem. 292:1679. PubMed
  83. Garcia–Esparcia P, et al. 2017. Front Neurol. 8:89. PubMed
  84. Lin TW, et al. 2017. PLoS One. 12:e0174561. PubMed
  85. Amar F, et al. 2017. Sci Signal. 10:478. PubMed
  86. López–Arias B, et al. 2017. PLoS One. 12:e0177541. PubMed
  87. Finke JM, et al. 2017. Biochim Biophys Acta. 1861:2228. PubMed
  88. Hu X, et al. 2017. Front Neuroanat. 11:45. PubMed
  89. Kedia N, et al. 2017. Phys Chem Chem Phys. 19:18036. PubMed
  90. Li N, et al. 2017. Curr Alzheimer Res. 14:1109. PubMed
  91. O'Reilly MA, et al. 2017. Theranostics. 7:3573. PubMed
  92. Welty S, et al. 2018. J Biol Chem. 293:1353. PubMed
  93. Ziegler–Waldkirch S, et al. 2018. EMBO J. 37:167. PubMed
  94. Ayaki T, et al. 2018. J Neuropathol Exp Neurol. 77:128. PubMed
  95. Lim CS, et al. 2018. Biosci Rep. 38:1. PubMed
  96. Söllvander S, et al. 2018. J Neuroinflammation. 15:98. PubMed
  97. Zhang JH, et al. 2018. BMC Complement Altern Med. 18:167. PubMed
  98. González C, et al. 2018. Mol Psychiatry. 23:2363. PubMed
  99. Fowler AJ, et al. 2019. Drugs R D. 19:149. PubMed
  100. Dyer M, et al. 2019. Front Aging Neurosci. 11:68. PubMed
  101. Xu L et al. 2019. Cell reports. 27(4):1293-1306 . PubMed
  102. Grant MKO, et al. 2019. Biol Proced Online. 21:6. PubMed
  103. Spangenberg E, et al. 2019. Nat Commun. 10:3758. PubMed
  104. Kiyota T, et al. 2018. J Neuroimmunol. 319:80. PubMed
  105. Chandra S, et al. 2019. J Alzheimers Dis Rep. 3:149. PubMed
  106. Gulisano W, et al. 2019. J Neurosci. 39:5986. PubMed
  107. Harper MM, et al. 2019. Invest Ophthalmol Vis Sci. 60:2716. PubMed
  108. Jonson M, et al. 2018. Cell Chem Biol. 25:595. PubMed
  109. Roitenberg N, et al. 2018. EMBO Rep. 19. PubMed
  110. Baek SH, et al. 2017. J Neurosci. 37:5099. PubMed
  111. Lisa Dolfe et al. 2018. Journal of Alzheimer's disease reports. 2(1):27-39 . PubMed
  112. Croft CL, et al. 2017. Cell Death Dis. 8:e2671. PubMed
  113. Valls–Comamala V, et al. 2017. Oncotarget. 8:41154. PubMed
  114. Paula PC, et al. 2019. Molecules. 24. PubMed
  115. Esposito G, et al. 2019. Mar Drugs. 17. PubMed
  116. Khan I, et al. 2018. Sci Rep. 8:12834. PubMed
  117. Bearer EL, et al. 2018. Neurobiol Aging. 70:276. PubMed
  118. Wendeln AC, et al. 2018. Nature. 556:332. PubMed
  119. Vargas–Restrepo F, et al. 2018. Biomedica. 38:69. PubMed
  120. Yadav DB, et al. 2017. Br J Pharmacol. 174:4173. PubMed
  121. Opazo P, et al. 2018. Cell Rep. 23:3137. PubMed
  122. Herzer S, et al. 2018. Front Mol Neurosci. 11:206. PubMed
  123. Plá V, et al. 2017. Front Mol Neurosci. 10:202. PubMed
  124. Spitzer P, et al. 2018. Front Aging Neurosci. 10:152. PubMed
  125. Serra–Batiste M, et al. 2018. Front Mol Biosci. 5:38. PubMed
  126. de Dios C, et al. 2019. Redox Biol. 26:101283. PubMed
  127. Merlini M et al. 2019. Neuron. 101(6):1099-1108 . PubMed
  128. Fiock KL et al. 2019. J Comp Neurol. 528(1):108-113 . PubMed
  129. Cecon E et al. 2019. Br J Pharmacol. 176(18):3475-3488 . PubMed
  130. Cline EN, et al. 2019. J Neurochem. 148:822. PubMed
  131. Abud EM et al. 2017. Neuron. 94(2):278-293 . PubMed
  132. Sebollela A et al. 2017. Journal of neurochemistry. 142(6):934-947 . PubMed
  133. Ye X et al. 2017. The Journal of Neuroscience. 37(10):2639-2655 . PubMed
  134. Huynh TV, et al. 2017. Neuron. 96:1013. PubMed
  135. Nobili A et al. 2017. Nature communications. 253:27:00 . PubMed
  136. Colvin BA, et al. 2017. J Neurochem. 143:736. PubMed
  137. Bove–Fenderson E, et al. 2017. J Biol Chem. 292:16858. PubMed
  138. Asam K, et al. 2017. PLoS One. 12:e0189413. PubMed
  139. Reinhardt S, et al. 2018. Sci Rep. 1.25625. PubMed
  140. Park JS, et al. 2018. Sensors (Basel). 18:00. PubMed
  141. Di Fede G, et al. 2018. Sci Rep. 2.603472222. PubMed
  142. Zhang L, et al. 2018. Neurobiol Dis. 114:01:00. PubMed
  143. Chandra S, et al. 2018. J Neurosci. 38:6682. PubMed
  144. Liu D, et al. 2018. Neurobiol Aging. 70:160. PubMed
  145. Chernick D, et al. 2018. J Neurochem. 147:647. PubMed
  146. Edler MK, et al. 2018. J Comp Neurol. 526:2921. PubMed
  147. Rubio–Araiz A, et al. 2018. J Neuroinflammation. 0.796527778. PubMed
  148. Kozin SA, et al. 2018. Front Neurosci. 0.859722222. PubMed
  149. Barykin EP, et al. 2018. Front Mol Neurosci. 0.668055556. PubMed
  150. Rosenberg RN, et al. 2018. Alzheimers Res Ther. 0.496527778. PubMed
  151. Keene CD, et al. 2019. Lab Invest. 99:1056. PubMed
  152. Stimmell AC, et al. 2019. Sci Rep. 1.285416667. PubMed
  153. Yang P, et al. 2019. BMC Immunol. 20:09. PubMed
  154. Braggin JE, et al. 2019. Ann Clin Transl Neurol. 0.779166667. PubMed
  155. Esquerda–Canals G, et al. 2019. PLoS One. 14:e0217793. PubMed
  156. Prakash P, et al. 2019. Methods Protoc. 2:48. PubMed
  157. Qin K, et al. 2019. Sci Rep. 6.294444444. PubMed
  158. Sheng L, et al. 2019. FASEB J. 33:10425. PubMed
  159. Li L, et al. 2019. Exp Neurobiol. 28:329. PubMed
  160. Shmueli MD, et al. 2017. J Biol Methods. 4:e69. PubMed
  161. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  162. Zysk M, et al. 2019. J Alzheimers Dis. 72:161. PubMed
  163. van Husen LS, et al. 2019. J Alzheimers Dis. 72:537. PubMed
  164. Hansson O, et al. 2019. Alzheimers Res Ther. 0.51875. PubMed
  165. Kollmer M, et al. 2019. Nat Commun. 3.722222222. PubMed
  166. Ding Y, et al. 2019. Front Neurol. 1.208333333. PubMed
  167. Cox LM, et al. 2019. Sci Rep. 9:17904. PubMed
  168. Pires G, et al. 2019. Acta Neuropathol Commun. 0.427083333. PubMed
  169. Beraldo FH, et al. 2019. Elife. 8:e49630. PubMed
  170. Lee HT, et al. 2019. J Neuroinflammation. 0.852083333. PubMed
  171. Medina CS, et al. 2019. Front Cell Neurosci. 0.889583333. PubMed
  172. Wang S, et al. 2019. Sci Rep. 9:19575. PubMed
  173. Hu T, et al. 2020. Aging (Albany NY). 0.834027778. PubMed
  174. Pi G, et al. 2020. Nat Commun. 0.585416667. PubMed
  175. Ren J, et al. 2020. Int J Clin Exp Pathol. 3.030555556. PubMed
  176. Yan T, et al. 2020. Nat Commun. 0.74375. PubMed
  177. Tambini MD, et al. 2020. Elife. 9:e52612. PubMed
  178. Fang EF, et al. 2019. Nat Neurosci. 22:401. PubMed
  179. Batarseh YS, et al. 2017. Neuroscience. 352:204. PubMed
  180. Sachdev R, et al. 2018. Mol Neurobiol. 55:8355. PubMed
  181. Kaya I, et al. 2017. ACS Chem Neurosci. 8:347. PubMed
  182. An Y, et al. 2020. Front Immunol. 11:162. PubMed
  183. Eede P, et al. 2020. EMBO Rep. 21:e48530. PubMed
  184. Zheng Y, et al. 2019. Brain. 142:787. PubMed
  185. Vu HT, et al. 2017. Sci Rep. 7:40205. PubMed
  186. Zhu X, et al. 2017. Aging Cell. 16:1073. PubMed
  187. Gerber H, et al. 2019. Acta Neuropathol Commun. 7:13. PubMed
  188. Yan T, et al. 2018. J Alzheimers Dis. 63:157. PubMed
  189. Imanikia S, et al. 2019. Cell Rep. 28:581. PubMed
  190. Imanikia S, et al. 2019. Curr Biol. 29:2322. PubMed
  191. Gee MS, et al. 2020. Alzheimers Res Ther. 12:45. PubMed
  192. Shi H, et al. 2020. Acta Neuropathol. 139:813. PubMed
  193. Bonds JA, et al. 2019. J Neurosci. 39:8576. PubMed
  194. Ren P, et al. 2020. Oxid Med Cell Longev. 2020:3050971. PubMed
  195. Calvo-Rodríguez M, et al. 2020. Nat Commun. 11:2146. PubMed
  196. Tambini MD, et al. 2020. J Biol Chem. 295:7442. PubMed
  197. Li S, et al. 2020. Front Immunol. 11:49. PubMed
  198. Chen X, et al. 2020. Nat Commun. 11:867. PubMed
  199. Schmidt K, et al. 2017. Mediators Inflamm. 2017:5470831. PubMed
  200. Buccarello L, et al. 2017. Oncotarget. 8:83038. PubMed
  201. Sogorb-Esteve A, et al. 2018. Mol Neurobiol. 55:5047. PubMed
  202. Pera M, et al. 2017. EMBO J. 36:3356. PubMed
  203. Brozzetti L, et al. 2020. Front Neurosci. 14:145. PubMed
  204. Wang D, et al. 2018. Neurosci Bull. 34:912. PubMed
  205. Van der Jeugd A, et al. 2018. Sci Rep. 8:6431. PubMed
  206. Readhead B, et al. 2018. Neuron. 99:64. PubMed
  207. Batarseh YS, et al. 2018. J Nutr Biochem. 55:113. PubMed
  208. Huichalaf CH, et al. 2019. Hum Mol Genet. 28:2014. PubMed
  209. Lahiri S, et al. 2019. Crit Care. 1.002083333. PubMed
  210. Baik SH, et al. 2020. Cell Metabolism. 30(3):493-507. PubMed
  211. Michno W, et al. 2020. Journal of Neurochemistry. 152(5):602-616.. PubMed
  212. Bai B, et al. 2020. Neuron. 105(6):975-991.e7.. PubMed
  213. Ghatak S, et al. 2020. eLife. 8:e50333.. PubMed
  214. Socodato R, et al. 2020. Cell Reports. 31(12):107796. PubMed
  215. Griner SL, et al. 2020. eLife. 8:e46924.. PubMed
  216. Shippy DC, et al. 2020. J Neuroinflammation. 0.902777778. PubMed
  217. Yao J, et al. 2020. Cell Rep. 32:108169. PubMed
  218. Li L, et al. 2020. Neural Plast. 2020:8836173. PubMed
  219. Goodman JR, et al. 2018. Brain Behav Immun. 73:34:00. PubMed
  220. Turnbull MT, et al. 2018. Front Mol Neurosci. 11:51. PubMed
RRID
AB_2564652 (BioLegend Cat. No. 803003)
AB_2715854 (BioLegend Cat. No. 803004)
AB_2564653 (BioLegend Cat. No. 803001)
AB_2564654 (BioLegend Cat. No. 803002)

Antigen Details

Structure
Amyloid precursor protein is a 770 amino acid protein with a molecular mass of ~100 kD. According to the UniProtKB database, APP (ID# P05067) has 11 isoforms (34 to ~90 kD) and the 770 form has been designated as the canonical form. Isoform APP695 is the predominant form expressed in neuronal tissue. Isoforms APP751 and APP770 are widely expressed in non-neuronal cells. Isoform APP751 is the most abundant form in T-lymphocytes. Aβ denotes peptides of 36-43 amino acids generated from cleavage of APP by secretases. Aβ has an apparent molecular mass of about 4 kD.
Distribution

Tissue distribution: Primarily nervous system, but also adipose tissue, intestine, muscle.
Cellular distribution: Cytosol, endosomes, nucleus, plasma membrane, extracellular, and golgi apparatus.

Function
The normal function of Aβ is not well understood. Several potential physiological roles have been proposed, including: activation of kinase enzymes; protection against oxidative stress; regulation of cholesterol transport; transcription factor, and as an anti-microbial agent.
Biology Area
Cell Biology, Neurodegeneration, Neuroscience, Protein Misfolding and Aggregation
Molecular Family
APP/β-Amyloid
Antigen References
  1. Kumar A, et al. 2015. Pharmacol. Rep. 67(2):195.
  2. Sadigh-Eteghad S, et al. 2015. Med. Princ. Pract. 24(1):1
  3. Hampel H, et al. 2015. Expert Rev. Neurother. 15(1):83.
  4. Puig KL, et al. 2012.  Exp. Gerontol. 48(7): 608.
  5. Selkoe DJ, et al. 2016. EMBO Mol. Med. 8(6):595.
  6. Walsh DM, et al.  2007. J. Neurochem. 101(5):1172.
Gene ID
351 View all products for this Gene ID
UniProt
View information about beta-Amyloid, 1-16 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 03/12/2021

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Biotin anti-β-Amyloid, 1-16

  • Alexa Fluor® 647 anti-β-Amyloid, 1-16

  • Spark YG™ 570 anti-β-Amyloid, 1-16

  • Ultra-LEAF™ Purified anti-β-Amyloid, 1-16

  • Alexa Fluor® 488 anti-β-Amyloid, 1-16

  • Anti-β-Amyloid, 1-16

  • HRP anti-β-Amyloid, 1-16

  • Alexa Fluor® 594 anti-β-Amyloid, 1-16

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account